We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

The Future of Lateral Flow
Industry Insight

We recently caught up with BBI’s Managing Director, Liam Taylor, to discuss the expansion of lateral flow testing as a tool for diagnostics and patient monitoring.

Read More

How Software Based Technologies Help Developing Precise and Effective in vitro Diagnostics
Industry Insight

We spoke to Dr Philipp Pagel, CMO at numares AG, to learn about some of the limitations of current in vitro diagnostics, and how software based technologies can help overcome some of these.

Read More

Uncovering the Dark Matter of Microbiota
Industry Insight

We spoke to Dirk Löffert, Ph.D., CEO of Biomillenia, to learn about some of the challenges of isolating live bacterial species, and how microbiome-on-a-chip technology can help overcome some of these.

Read More

Unlocking The Full Potential of Organoids
Industry Insight

To learn about the importance of the extracellular matrix and some of the limitations of current organoid culture systems, we spoke to Colin Sanctuary, CEO and founder of QGel, a spin-out from EPFL.

Read More

Increasing Diagnostic Certainty with Optical Biopsies
Industry Insight

We spoke to Dr Sacha Loiseau, developer of Cellvizio®, to learn more about optical biopsy and the benefits it can bring to the clinic.

Read More

The World's Largest Human Proteome Microarray: Advancing Protein Biomarker Discovery
Industry Insight

CDI’s content of 81% of the human proteome (>23,000 proteins) is the largest human protein array in the world.

Read More

The Tiny Pump with Big Applications
Industry Insight

We spoke to Tom Harrison, Business Development Manager, TTP Ventus, to learn more about the technology behind Disc Pump, and some of the applications it could benefit.

Read More

Tackling the Opioid Crisis: Genetic testing to identify addiction risk
Industry Insight

Dr Keri Donaldson, CEO and founder of predictive health intelligence company Prescient Medicine, tells us about the role that genetic testing could play in tackling the opioid crisis.

Read More

Multiplex Testing Informs STI Treatment Pathways
Industry Insight

Bacterial resistance to antibiotics is a growing concern, and is no less prevalent among pathogens causing sexually transmitted infections. Colin Denver tells us about the success of a multiplex diagnostics approach in testing azithromycin resistance in Mycoplasma genitalium.

Read More

Point-of-Care Testing for Peritoneal Dialysis Patients
Industry Insight

We spoke to Barbara Fallowfield to learn about the test, the benefits it can offer patients, and the role that point-of-care tests may play in the future of healthcare.

Read More

 
Advertisement